And it’s not just Sarepta (3 drugs approved by FDA) working in this space. AVI Biopharma, Pepgen, Prosensa NS Pharma (one drug approved by FDA) and others are also working on exon skipping for DMD. Possible multiple licencing deals?.. “one article states “researchers hope that “cocktails” of antisense oligonucleotides that target multiple exons can be developed that might help a substantial portion of the DMD population”.. yet exon skipping only works for 13% of the patients. 1102 can also be used for inflammation to compliment these treatments and can be used on all DMD boys…and then there is Beckers..
- Forums
- ASX - By Stock
- PER
- Ann: Positive new DMD Combination Therapy Data in mdx mice
Ann: Positive new DMD Combination Therapy Data in mdx mice, page-25
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.0¢ |
Change
0.004(5.26%) |
Mkt cap ! $72.12M |
Open | High | Low | Value | Volume |
7.9¢ | 8.0¢ | 7.7¢ | $35.48K | 451.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 12500 | 7.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 198147 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1471 | 0.077 |
1 | 69866 | 0.074 |
1 | 75000 | 0.073 |
2 | 15000 | 0.070 |
1 | 100000 | 0.067 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 198147 | 2 |
0.081 | 198015 | 2 |
0.082 | 75174 | 2 |
0.083 | 93000 | 1 |
0.084 | 200300 | 2 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |